Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA.
Patrick T CampbellLisa B VanWagnerLaura A ColangeloCora E LewisAnne HenkelVeeral H AjmeraDonald M Lloyd-JonesDouglas E VaughanSadiya S KhanPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Plasma PAI-1 levels in young adulthood were independently associated with NAFLD in midlife. Further studies may indicate whether PAI-1 plays a role in NAFLD pathophysiology.